Understanding how inflammation affects pancreatic diseases

Who could benefit from this research

What this research studies

This research investigates the role of inflammation in pancreatic diseases, focusing on how reactive oxygen species (ROS) contribute to conditions like pancreatitis and pancreatic cancer. By examining the molecular mechanisms involved, particularly the behavior of mutant KRAS genes under inflammatory conditions, the study aims to uncover new therapeutic targets. Patients may benefit from insights that could lead to better prevention and treatment strategies for pancreatic disorders. The research employs a combination of laboratory experiments and analysis of genetic factors related to inflammation.

Why it matters

Where this research is happening

• University of Texas El Paso
  El Paso, United States Active

Researchers

• Principal investigator: Lu, Weiqin — University of Texas El Paso
• Study coordinator: Lu, Weiqin

Related research

Other NIH-funded projects on the same topics.

• Conference on pancreatic diseases and new treatment targets

  This conference is a friendly gathering for experts to share new ideas and discoveries about pancreatic diseases like diabetes and cancer, helping to improve understanding and treatment for everyone affected by these conditions.

  NIH research Gordon Research Conferences · East Greenwich, UNITED STATES · NIH-11165695

• Intensive 4-week postoperative multimodal rehab after proximal pancreatic surgery

  This study tests whether a 4-week multimodal rehabilitation program can help adults who have severe complications after proximal pancreatic surgery recover better.

  Recruiting IRCCS San Raffaele · Milan · NCT07768384

• New lipase NHS7108 safety and potential efficacy in adults with exocrine pancreatic insufficiency

  A 2-period study tests whether the new lipase NHS7108 works safely for adults with EPI by comparing it to the standard pancrelipase (Zenpep) at several doses over 14 days each.

  Recruiting at 7 sites Phase 2 Société des Produits Nestlé (SPN) · Scottsdale, Arizona and 38 other locations · NCT07559175

• Dabrafenib and trametinib for rare cancers with BRAF V600 mutations

  This arm tests whether dabrafenib and trametinib can help adults, children, and teens with cancers that have a BRAF V600 mutation.

  Recruiting at 15 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT07440290

• Early diagnosis of pancreatic cancer using duodenal fluid biomarkers

  This project will see if pancreatic fluid collected during routine endoscopy can help detect early pancreatic cancer in adults.

  Recruiting at 3 sites Asan Medical Center · Aurora, Colorado and 2 other locations · NCT07030348

• Paracetamol with ibuprofen versus paracetamol with metamizole for pain in children with acute pancreatitis

  We will test whether IV paracetamol combined with ibuprofen or IV paracetamol combined with metamizole reduces pain more effectively in children aged 3–18 with acute pancreatitis.

  Recruiting Phase 4 Medical University of Warsaw · Warsaw · NCT07024199

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.